Folgen
Emmanuel André
Emmanuel André
Bestätigte E-Mail-Adresse bei cumulus.uzleuven.be
Titel
Zitiert von
Zitiert von
Jahr
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
D Planas, N Saunders, P Maes, F Guivel-Benhassine, C Planchais, ...
Nature 602 (7898), 671-675, 2022
13332022
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
L Vangeel, W Chiu, S De Jonghe, P Maes, B Slechten, J Raymenants, ...
Antiviral research 198, 105252, 2022
3942022
Symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection by a phylogenetically distinct strain
J Van Elslande, P Vermeersch, K Vandervoort, T Wawina-Bokalanga, ...
Clinical Infectious Diseases 73 (2), 354-356, 2021
3532021
Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients
J Van Elslande, E Houben, M Depypere, A Brackenier, S Desmet, ...
Clinical Microbiology and Infection 26 (8), 1082-1087, 2020
2852020
Serum neutralization of SARS-CoV-2 Omicron sublineages BA. 1 and BA. 2 in patients receiving monoclonal antibodies
T Bruel, J Hadjadj, P Maes, D Planas, A Seve, I Staropoli, ...
Nature medicine 28 (6), 1297-1302, 2022
2562022
Results from early programmatic implementation of Xpert MTB/RIF testing in nine countries
J Creswell, AJ Codlin, E Andre, MA Micek, A Bedru, EJ Carter, RP Yadav, ...
BMC infectious diseases 14, 1-12, 2014
2182014
A sister lineage of the Mycobacterium tuberculosis complex discovered in the African Great Lakes region
JCS Ngabonziza, C Loiseau, M Marceau, A Jouet, F Menardo, O Tzfadia, ...
Nature communications 11 (1), 2917, 2020
1742020
Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study
NA Makhado, E Matabane, M Faccin, C Pinçon, A Jouet, F Boutachkourt, ...
The Lancet Infectious Diseases 18 (12), 1350-1359, 2018
1512018
Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs
J Van Elslande, B Decru, S Jonckheere, E Van Wijngaerden, E Houben, ...
Clinical Microbiology and Infection 26 (11), 1557. e1-1557. e7, 2020
1432020
The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis
TM Walker, P Miotto, CU Köser, PW Fowler, J Knaggs, Z Iqbal, M Hunt, ...
The Lancet Microbe 3 (4), e265-e273, 2022
1372022
Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection
J Van Elslande, M Oyaert, S Ailliet, M Van Ranst, N Lorent, ...
Journal of Clinical Virology 136, 104765, 2021
1332021
Resistance of Omicron subvariants BA. 2.75. 2, BA. 4.6, and BQ. 1.1 to neutralizing antibodies
D Planas, T Bruel, I Staropoli, F Guivel-Benhassine, F Porrot, P Maes, ...
Nature communications 14 (1), 824, 2023
1272023
The omicron (B. 1.1. 529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters
R Abdelnabi, CS Foo, X Zhang, V Lemmens, P Maes, B Slechten, ...
Antiviral research 198, 105253, 2022
1232022
Consensus numbering system for the rifampicin resistance-associated rpoB gene mutations in pathogenic mycobacteria
E André, L Goeminne, A Cabibbe, P Beckert, BK Mukadi, V Mathys, ...
Clinical Microbiology and Infection 23 (3), 167-172, 2017
1052017
A phylodynamic workflow to rapidly gain insights into the dispersal history and dynamics of SARS-CoV-2 lineages
S Dellicour, K Durkin, SL Hong, B Vanmechelen, J Martí-Carreras, MS Gill, ...
Molecular biology and evolution 38 (4), 1608-1613, 2021
922021
Considerable escape of SARS-CoV-2 variant Omicron to antibody neutralization
D Planas, N Saunders, P Maes, F Guivel-Benhassine, C Planchais, ...
BioRxiv, 2021.12. 14.472630, 2021
912021
Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs
A Jouet, C Gaudin, N Badalato, C Allix-Béguec, S Duthoy, A Ferré, ...
European Respiratory Journal 57 (3), 2021
842021
Novel rapid PCR for the detection of Ile491Phe rpoB mutation of Mycobacterium tuberculosis, a rifampicin-resistance-conferring mutation undetected by commercial assays
E André, L Goeminne, A Colmant, P Beckert, S Niemann, M Delmée
Clinical Microbiology and Infection 23 (4), 267. e5-267. e7, 2017
532017
Diagnostic performance of smear microscopy and incremental yield of Xpert in detection of pulmonary tuberculosis in Rwanda
JCS Ngabonziza, W Ssengooba, F Mutua, G Torrea, A Dushime, ...
BMC infectious diseases 16, 1-7, 2016
532016
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA. 2, BA. 4, and BA. 5 in patients receiving monoclonal antibodies
T Bruel, K Stéfic, Y Nguyen, D Toniutti, I Staropoli, F Porrot, ...
Cell Reports Medicine 3 (12), 2022
522022
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20